Scholarlink

<p>The role of innervation in the pathogenesis of malignancies has been documented in many investigations. Recent studies have revealed that neurotransmitters act as mediators in nerve-stimulated cancer progression by directly influencing tumor cells and modulating the tumor microenvironment, including immune cells, angiogenesis, and surrounding stromal cells. Notably, psychological stress has been identified as a contributing factor to oncogenesis, primarily mediated by neurotransmitters. However, the complex interplay between neurotransmitters and tumor cells remains only partially understood. In this review, we explore newly identified mechanisms through which neurotransmitters (acetylcholine, glutamate, serotonin, dopamine, adrenaline, noradrenaline, γ-aminobutyric acid, neurotensin, and neuropeptide Y) regulate cancer initiation and progression, along with potential therapeutic strategies derived from these findings.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Neurotransmitters in tumors: chemical cross-talk shaping tumor progression

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月14日

查看全文
  • Wenting Chen,
  • Jie Yu,
  • Shengfang Ge,
  • Tifei Yuan,
  • Xianting Ding,
  • Biao Yan,
  • Lin Ye,
  • Yefei Wang,
  • Renbing Jia

摘要

The role of innervation in the pathogenesis of malignancies has been documented in many investigations. Recent studies have revealed that neurotransmitters act as mediators in nerve-stimulated cancer progression by directly influencing tumor cells and modulating the tumor microenvironment, including immune cells, angiogenesis, and surrounding stromal cells. Notably, psychological stress has been identified as a contributing factor to oncogenesis, primarily mediated by neurotransmitters. However, the complex interplay between neurotransmitters and tumor cells remains only partially understood. In this review, we explore newly identified mechanisms through which neurotransmitters (acetylcholine, glutamate, serotonin, dopamine, adrenaline, noradrenaline, γ-aminobutyric acid, neurotensin, and neuropeptide Y) regulate cancer initiation and progression, along with potential therapeutic strategies derived from these findings.